Starting SSRI and Lamotrigine in Bipolar II Depression
Start lamotrigine first and titrate it slowly over 6 weeks to minimize serious rash risk, then add an SSRI once the patient is on a therapeutic dose of lamotrigine (or at minimum, once lamotrigine is established as a mood stabilizer). This sequential approach prioritizes safety while ensuring mood stabilization before introducing antidepressant therapy.
Rationale for Sequential Initiation
The evidence strongly supports starting with a mood stabilizer before adding an antidepressant in bipolar depression. Antidepressants should only be used as adjuncts when the patient is already taking at least one mood stabilizer 1. This is critical because:
- SSRIs carry risk of mood destabilization or precipitating manic/hypomanic episodes when used without mood stabilizer coverage 1
- The switch rate to (hypo)mania with antidepressants is minimized when given concurrently with mood stabilizers 2
- Lamotrigine has demonstrated efficacy for bipolar depression with relatively low switch risk 3, 4
Lamotrigine Titration Schedule
Lamotrigine must be titrated slowly over 6 weeks to reach the target dose of 200 mg/day 4. This gradual titration is non-negotiable because:
- The incidence of serious rash (including Stevens-Johnson syndrome) is 0.1% with proper titration 4
- Rapid titration significantly increases this risk
- The standard titration minimizes dermatologic complications while maintaining efficacy
Critical Titration Adjustments
If the patient will eventually need valproate, lamotrigine dosing must be adjusted 4. Valproate significantly increases lamotrigine levels, requiring lower initial and target doses. Conversely, carbamazepine decreases lamotrigine levels and requires higher dosing 4, 5.
When to Add the SSRI
Add the SSRI after lamotrigine has been titrated to at least a therapeutic level (ideally after the full 6-week titration to 200 mg/day). The evidence suggests:
- SSRIs have demonstrated efficacy for bipolar depression when combined with mood stabilizers 2, 6
- The combination approach provides better outcomes than monotherapy for acute bipolar depression 2
- Starting both simultaneously increases complexity and makes it difficult to identify which agent is causing any adverse effects, including mood destabilization
Monitoring for Switch Risk
Once the SSRI is added, monitor closely for:
- Hypomanic or manic symptoms (agitation, decreased need for sleep, increased energy, racing thoughts)
- Mood destabilization or rapid cycling
- Increased anxiety or activation symptoms
If manic symptoms emerge with the SSRI, this may represent either unmasking of the disorder or medication-induced disinhibition 1. The SSRI should be reduced or discontinued while maintaining the lamotrigine.
Common Pitfalls to Avoid
- Never start an SSRI without mood stabilizer coverage in bipolar disorder - this substantially increases switch risk
- Do not rush lamotrigine titration - the slow titration is essential for safety, not optional
- Do not assume all antidepressants have equal switch risk - SSRIs have lower switch rates than tricyclic antidepressants 3
- Remember that maintenance treatment differs from acute treatment - there are indications that long-term combination of mood stabilizer plus antidepressant may increase switch risk compared to mood stabilizer alone 3, so plan to reassess the need for continued SSRI after acute response
Alternative First-Line Considerations
If more rapid treatment is needed, quetiapine monotherapy or lurasidone (with lithium or divalproex) are first-line alternatives that don't require the 6-week lamotrigine titration 7. These options provide faster onset of antidepressant effect while maintaining mood stability.